CGON
CG Oncology, Inc.
62.40$
-2.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | +50.0% | +13.3% | +88.2% | +4,415.6% | |
| – | -39.2% | +126.0% | +646.2% | +134.0% | |
| – | – | -22.5% | -15.5% | -21.7% | |
| – | -85.6% | -100.0% | – | -42.7% | |
| – | +56,963.9% | +119.0% | +148.2% | -18.3% | |
| – | -100.0% | – | -97.8% | -100.0% | |
| – | +674.9% | -27.3% | +622.2% | -75.6% | |
| – | +1,937.5% | -331.3% | – | -190.3% | |
| – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.